. . . . . . . . . "alecensa is indicated for the treatment of patients with anaplastic lymphoma kinase alk positive metastatic non small cell lung cancer nsclc as detected by an fda approved test alecensa is a kinase inhibitor indicated for the treatment of patients with anaplastic lymphoma kinase alk positive metastatic non small cell lung cancer nsclc as detected by an fda approved test 1" . . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "SDY4nf+rJbnG7663eQB0naOJiOYdfId9JAbIX8K6TJpz85nPPPVfqoHk7Lg4QztN1dvELwEOgCNjWGVGVMVn3GMfAjMEYzRNvmkTV23/XCS/wTTranHAwPpkiFdKzl1hsL5iCqc2lGzsYofx+BT/GC2ocHTWXT8KJnaE2X0UfWI=" . . "2021-07-03T14:52:14.244+02:00"^^ . . . . .